53BP1 as a potential predictor of response in PARP inhibitor-treated homologous recombination-deficient ovarian cancer

RM Hurley; AEW Hendrickson; DW Visscher; P Ansel; MI Harrell; JM Wagner; V Negron; KM Goergen; M J Maurer; A L Oberg; XW Meng; KS Flatten; Maja de Jonge; CD Van Herpen; JA Gietema; RHT Koornstra; Agnes Jager; M W den Hollander; M Dudley; SP Shepherd; EM Swisher; S H Kaufmann

doi:10.1016/j.ygyno.2019.01.015

53BP1 as a potential predictor of response in PARP inhibitor-treated homologous recombination-deficient ovarian cancer

RM Hurley, AEW Hendrickson, DW Visscher, P Ansel, MI Harrell, JM Wagner, V Negron, KM Goergen, M J Maurer, A L Oberg, XW Meng, KS Flatten, Maja de Jonge, CD Van Herpen, JA Gietema, RHT Koornstra, Agnes Jager, M W den Hollander, M Dudley, SP ShepherdEM Swisher, S H Kaufmann

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

54 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	127-134
Number of pages	8
Journal	Gynecologic Oncology
Volume	153
Issue number	1
DOIs	https://doi.org/10.1016/j.ygyno.2019.01.015
Publication status	Published - 2019

Research programs

EMC MM-03-86-08

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ygyno.2019.01.015

http://hdl.handle.net/1765/116068

Cite this

Hurley, RM., Hendrickson, AEW., Visscher, DW., Ansel, P., Harrell, MI., Wagner, JM., Negron, V., Goergen, KM., Maurer, M. J., Oberg, A. L., Meng, XW., Flatten, KS., de Jonge, M., Van Herpen, CD., Gietema, JA., Koornstra, RHT., Jager, A., den Hollander, M. W., Dudley, M., ... Kaufmann, S. H. (2019). 53BP1 as a potential predictor of response in PARP inhibitor-treated homologous recombination-deficient ovarian cancer. Gynecologic Oncology, 153(1), 127-134. https://doi.org/10.1016/j.ygyno.2019.01.015

@article{c9c3604e318c484ba08075d4213f20d7,

title = "53BP1 as a potential predictor of response in PARP inhibitor-treated homologous recombination-deficient ovarian cancer",

author = "RM Hurley and AEW Hendrickson and DW Visscher and P Ansel and MI Harrell and JM Wagner and V Negron and KM Goergen and Maurer, {M J} and Oberg, {A L} and XW Meng and KS Flatten and {de Jonge}, Maja and {Van Herpen}, CD and JA Gietema and RHT Koornstra and Agnes Jager and {den Hollander}, {M W} and M Dudley and SP Shepherd and EM Swisher and Kaufmann, {S H}",

year = "2019",

doi = "10.1016/j.ygyno.2019.01.015",

language = "Undefined/Unknown",

volume = "153",

pages = "127--134",

journal = "Gynecologic Oncology",

issn = "0090-8258",

publisher = "Academic Press",

number = "1",

}

Hurley, RM, Hendrickson, AEW, Visscher, DW, Ansel, P, Harrell, MI, Wagner, JM, Negron, V, Goergen, KM, Maurer, MJ, Oberg, AL, Meng, XW, Flatten, KS, de Jonge, M, Van Herpen, CD, Gietema, JA, Koornstra, RHT, Jager, A, den Hollander, MW, Dudley, M, Shepherd, SP, Swisher, EM & Kaufmann, SH 2019, '53BP1 as a potential predictor of response in PARP inhibitor-treated homologous recombination-deficient ovarian cancer', Gynecologic Oncology, vol. 153, no. 1, pp. 127-134. https://doi.org/10.1016/j.ygyno.2019.01.015

TY - JOUR

T1 - 53BP1 as a potential predictor of response in PARP inhibitor-treated homologous recombination-deficient ovarian cancer

AU - Hurley, RM

AU - Hendrickson, AEW

AU - Visscher, DW

AU - Ansel, P

AU - Harrell, MI

AU - Wagner, JM

AU - Negron, V

AU - Goergen, KM

AU - Maurer, M J

AU - Oberg, A L

AU - Meng, XW

AU - Flatten, KS

AU - de Jonge, Maja

AU - Van Herpen, CD

AU - Gietema, JA

AU - Koornstra, RHT

AU - Jager, Agnes

AU - den Hollander, M W

AU - Dudley, M

AU - Shepherd, SP

AU - Swisher, EM

AU - Kaufmann, S H

PY - 2019

Y1 - 2019

U2 - 10.1016/j.ygyno.2019.01.015

DO - 10.1016/j.ygyno.2019.01.015

M3 - Article

C2 - 30686551

SN - 0090-8258

VL - 153

SP - 127

EP - 134

JO - Gynecologic Oncology

JF - Gynecologic Oncology

IS - 1

ER -